Literature DB >> 19615767

Measuring the adherence to medication of elderly patients with heart failure: is there a gold standard?

Helen Smith, Matthew Hankins, Andrew Hodson, Charles George.   

Abstract

ACE inhibitors and loop diuretics are treatments of first choice for heart failure, but patients must take their medications regularly to achieve maximum benefit. Adherence is commonly assessed using pill counts, self-report or electronic monitoring, with the latter widely considered the 'gold standard'. We assessed the concordance of these three methods in a sample of 52 elderly patients with heart failure over a six-week period. Substantial differences in adherence were found between the three methods. Adherence by self-report was very high for both ACE-I and diuretic, with little between-person variation. This was, however, uncorroborated by pill count and electronic monitoring. Closer examination of the electronic record suggested that the mean level of adherence overlooked patterns of openings more consistent with adherent behaviour. There seems to be no gold standard for measurement of adherence in this population.
Copyright © 2010. Published by Elsevier Ireland Ltd.

Entities:  

Mesh:

Year:  2009        PMID: 19615767     DOI: 10.1016/j.ijcard.2009.06.031

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  8 in total

Review 1.  Concordance of Adherence Measurement Using Self-Reported Adherence Questionnaires and Medication Monitoring Devices: An Updated Review.

Authors:  Alisha Monnette; Yichen Zhang; Hui Shao; Lizheng Shi
Journal:  Pharmacoeconomics       Date:  2018-01       Impact factor: 4.981

2.  Use of a urine anastrozole assay to determine treatment discontinuation among women with hormone-sensitive breast cancer: a pilot study.

Authors:  Grace Clarke Hillyer; Alfred I Neugut; Katherine D Crew; Kevin Kalinsky; Matthew A Maurer; Demetra Z Rotsides; Jonathan Danaceau; Dawn L Hershman
Journal:  J Oncol Pract       Date:  2012-06-26       Impact factor: 3.840

3.  Better adherence to treatment recommendations in heart failure predicts improved cognitive function at a one-year follow-up.

Authors:  Michael L Alosco; Mary Beth Spitznagel; Ronald Cohen; Lawrence H Sweet; Richard Josephson; Joel Hughes; Jim Rosneck; John Gunstad
Journal:  J Clin Exp Neuropsychol       Date:  2014-10-29       Impact factor: 2.475

4.  In search of a standard when analyzing medication adherence in patients with heart failure using claims data: a systematic review.

Authors:  Katrin Krueger; Nina Griese-Mammen; Ingrid Schubert; Marita Kieble; Lea Botermann; Ulrich Laufs; Charlotte Kloft; Martin Schulz
Journal:  Heart Fail Rev       Date:  2018-01       Impact factor: 4.214

5.  Cognitive function and treatment adherence in older adults with heart failure.

Authors:  Michael L Alosco; Mary Beth Spitznagel; Manfred van Dulmen; Naftali Raz; Ronald Cohen; Lawrence H Sweet; Lisa H Colbert; Richard Josephson; Joel Hughes; Jim Rosneck; John Gunstad
Journal:  Psychosom Med       Date:  2012-10-31       Impact factor: 4.312

6.  Adherence to Bisphosphonates among People Admitted to an Orthopaedic and Geriatric Ward at a University Hospital in Sweden.

Authors:  Linnea Abramsson; Maria Gustafsson
Journal:  Pharmacy (Basel)       Date:  2018-02-28

7.  Measurement Properties of Existing Patient-Reported Outcome Measures on Medication Adherence: Systematic Review.

Authors:  Yu Heng Kwan; Si Dun Weng; Dionne Hui Fang Loh; Truls Østbye; Lian Leng Low; Hayden Barry Bosworth; Julian Thumboo; Jie Kie Phang; Livia Jia Yi Oo; Dan V Blalock; Eng Hui Chew; Kai Zhen Yap; Corrinne Yong Koon Tan; Sungwon Yoon; Warren Fong
Journal:  J Med Internet Res       Date:  2020-10-09       Impact factor: 5.428

8.  Quality of Life and Medication Adherence of Independently Living Older Adults Enrolled in a Pharmacist-Based Medication Management Program.

Authors:  Christopher Harlow; Catherine Hanna; Lynne Eckmann; Yevgeniya Gokun; Faika Zanjani; Karen Blumenschein; Holly Divine
Journal:  Pharmacy (Basel)       Date:  2017-04-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.